Literature DB >> 10557323

Syncytiotrophoblastic giant cells in teratocarcinoma-like tumors derived from Parp-disrupted mouse embryonic stem cells.

T Nozaki1, M Masutani, M Watanabe, T Ochiya, F Hasegawa, H Nakagama, H Suzuki, T Sugimura.   

Abstract

The enzyme poly(ADP-ribose) polymerase (Parp) catalyzes poly(ADP-ribosyl)ation reaction and is involved in DNA repair and cell death induction upon DNA damages. Meanwhile, poly(ADP-ribosyl)ation of chromosome-associated proteins is suggested to be implicated in the regulation of gene expression and cellular differentiation, both of which are important in tumorigenesis. To investigate directly the role of Parp deficiency in tumorigenicity and differentiation of embryonic stem (ES) cells during tumor formation, studies were conducted by using wild-type J1 (Parp(+/+)) ES cells and Parp(+/-) and Parp(-/-) ES clones generated by disrupting Parp exon 1. These ES cells, irrespective of the Parp genotype, produced tumors phenotypically similar to teratocarcinoma when injected s.c. into nude mice. Remarkably, all tumors derived from Parp(-/-) clones contained syncytiotrophoblastic giant cells (STGCs), which possess single or multiple megalo-nuclei. The STGCs were present within large areas of intratumoral hemorrhage. In contrast, neither STGC nor hemorrhage was observed in tumors of both wild-type J1 cells and Parp(+/-) clones. Electron microscopic examination showed that the STGCs possess microvilli on the cell surface and contained secretory granules in the cytoplasm. Furthermore, the cytoplasms of STGCs were strongly stained with antibody against mouse prolactin, which could similarly stain trophoblasts in placenta. These morphological and histochemical features indicate that the STGCs in teratocarcinoma-like tumors derived from Parp(-/-) clones belong to the trophoblast cell lineage. Our findings thus suggest that differentiation of ES cells into STGCs was possibly induced by the lack of Parp during the development of teratocarcinoma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10557323      PMCID: PMC23950          DOI: 10.1073/pnas.96.23.13345

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  cis-acting elements and trans-acting proteins in the transcription of chorionic gonadotropin/luteinizing hormone receptor gene in human choriocarcinoma cells and placenta.

Authors:  Y L Hu; Z M Lei; C V Rao
Journal:  Endocrinology       Date:  1996-09       Impact factor: 4.736

2.  Reversion of malignant phenotype by 5-iodo-6-amino-1,2-benzopyrone a non-covalently binding ligand of poly(ADP-ribose) polymerase.

Authors:  P I Bauer; E Kirsten; G Varadi; L J Young; A Hakam; J A Comstock; E Kun
Journal:  Biochimie       Date:  1995       Impact factor: 4.079

3.  Poly(ADP-ribose) polymerase enhances activator-dependent transcription in vitro.

Authors:  M Meisterernst; G Stelzer; R G Roeder
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

4.  Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease.

Authors:  Z Q Wang; B Auer; L Stingl; H Berghammer; D Haidacher; M Schweiger; E F Wagner
Journal:  Genes Dev       Date:  1995-03-01       Impact factor: 11.361

5.  Essential role of Mash-2 in extraembryonic development.

Authors:  F Guillemot; A Nagy; A Auerbach; J Rossant; A L Joyner
Journal:  Nature       Date:  1994-09-22       Impact factor: 49.962

6.  Embryonic stem (ES) cells lacking functional c-jun: consequences for growth and differentiation, AP-1 activity and tumorigenicity.

Authors:  F Hilberg; E F Wagner
Journal:  Oncogene       Date:  1992-12       Impact factor: 9.867

7.  Molecular cloning and expression of mouse placental lactogen I complementary deoxyribonucleic acid.

Authors:  P Colosi; F Talamantes; D I Linzer
Journal:  Mol Endocrinol       Date:  1987-11

8.  Requirement for the expression of poly(ADP-ribose) polymerase during the early stages of differentiation of 3T3-L1 preadipocytes, as studied by antisense RNA induction.

Authors:  M E Smulson; V H Kang; J M Ntambi; D S Rosenthal; R Ding; C M Simbulan
Journal:  J Biol Chem       Date:  1995-01-06       Impact factor: 5.157

9.  Hxt encodes a basic helix-loop-helix transcription factor that regulates trophoblast cell development.

Authors:  J C Cross; M L Flannery; M A Blanar; E Steingrimsson; N A Jenkins; N G Copeland; W J Rutter; Z Werb
Journal:  Development       Date:  1995-08       Impact factor: 6.868

10.  Polytene chromosomes in mouse trophoblast giant cells.

Authors:  S Varmuza; V Prideaux; R Kothary; J Rossant
Journal:  Development       Date:  1988-01       Impact factor: 6.868

View more
  10 in total

Review 1.  PARP and PARG inhibitors--new therapeutic targets in cancer treatment.

Authors:  Nilufer Jasmine Selimah Fauzee; Juan Pan; Ya-lan Wang
Journal:  Pathol Oncol Res       Date:  2010-04-12       Impact factor: 3.201

2.  Fibroblast growth factor regulates human neuroectoderm specification through ERK1/2-PARP-1 pathway.

Authors:  Young Dong Yoo; Cindy T Huang; Xiaoqing Zhang; Timothy M Lavaute; Su-Chun Zhang
Journal:  Stem Cells       Date:  2011-12       Impact factor: 6.277

3.  Insulin receptor substrate (IRS)-1 regulates murine embryonic stem (mES) cells self-renewal.

Authors:  Raphael Rubin; Alla Arzumanyan; Angela Rachele Soliera; Brian Ross; Francesca Peruzzi; Marco Prisco
Journal:  J Cell Physiol       Date:  2007-11       Impact factor: 6.384

4.  Stem cells, senescence, neosis and self-renewal in cancer.

Authors:  Rengaswami Rajaraman; Duane L Guernsey; Murali M Rajaraman; Selva R Rajaraman
Journal:  Cancer Cell Int       Date:  2006-11-08       Impact factor: 5.722

5.  Spontaneous Development of Dental Dysplasia in Aged Parp-1 Knockout Mice.

Authors:  Hisako Fujihara; Tadashige Nozaki; Masahiro Tsutsumi; Mayu Isumi; Shinji Shimoda; Yoshiki Hamada; Mitsuko Masutani
Journal:  Cells       Date:  2019-09-27       Impact factor: 6.600

6.  Loss of Parp-1 affects gene expression profile in a genome-wide manner in ES cells and liver cells.

Authors:  Hideki Ogino; Tadashige Nozaki; Akemi Gunji; Miho Maeda; Hiroshi Suzuki; Tsutomu Ohta; Yasufumi Murakami; Hitoshi Nakagama; Takashi Sugimura; Mitsuko Masutani
Journal:  BMC Genomics       Date:  2007-02-07       Impact factor: 3.969

7.  ADP-ribosyltransferases Parp1 and Parp7 safeguard pluripotency of ES cells.

Authors:  Stephen J Roper; Stephanie Chrysanthou; Claire E Senner; Arnold Sienerth; Stefano Gnan; Alexander Murray; Mitsuko Masutani; Paulina Latos; Myriam Hemberger
Journal:  Nucleic Acids Res       Date:  2014-07-17       Impact factor: 16.971

Review 8.  Potential role of epigenetic mechanisms in regulation of trophoblast differentiation, migration, and invasion in the human placenta.

Authors:  Hamid-Reza Kohan-Ghadr; Leena Kadam; Chandni Jain; D Randall Armant; Sascha Drewlo
Journal:  Cell Adh Migr       Date:  2016-01-08       Impact factor: 3.405

Review 9.  Role of novel histone modifications in cancer.

Authors:  Muthu K Shanmugam; Frank Arfuso; Surendar Arumugam; Arunachalam Chinnathambi; Bian Jinsong; Sudha Warrier; Ling Zhi Wang; Alan Prem Kumar; Kwang Seok Ahn; Gautam Sethi; Manikandan Lakshmanan
Journal:  Oncotarget       Date:  2017-12-17

Review 10.  A Survey of Essential Genome Stability Genes Reveals That Replication Stress Mitigation Is Critical for Peri-Implantation Embryogenesis.

Authors:  Georgia R Kafer; Anthony J Cesare
Journal:  Front Cell Dev Biol       Date:  2020-05-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.